PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
11829461-2	2002	Pioglitazone (1 mg/kg BW) prevented pericentral fibrosis and induction of alpha-smooth muscle actin (SMA) 72 h after CCl(4) administration (1 ml/kg BW).	Pioglitazone	0-12	actin gamma 2, smooth muscle	Rattus norvegicus	74-99	
9370113-10	1997	Treatment with pioglitazone reduced the amount of anti-alpha-smooth muscle actin antibody-staining cells.	Pioglitazone	15-27	actin gamma 2, smooth muscle	Rattus norvegicus	55-80	
23127227-8	2012	Pioglitazone significantly reduced the degree of hepatic steatosis and fibrosis, as well as serum concentrations of aminotransaminase, TG, FFA, glucose, insulin and TGF-beta1 and hepatic expression of alpha-SMA and collagen I protein.	Pioglitazone	0-12	actin gamma 2, smooth muscle	Rattus norvegicus	201-210	
21034856-5	2011	RESULTS: Western blot analysis revealed that AAC enhanced expression of monocyte chemoattractant protein (MCP)-1, transforming growth factor-beta1 and alpha-smooth muscle actin in the left atrium (LA), which was suppressed by pioglitazone.	Pioglitazone	226-238	actin gamma 2, smooth muscle	Rattus norvegicus	151-176	
16085455-7	2005	In the 16-week model, treatment for 4 weeks with PGZ ameliorated hepatic fibrosis with a decrease in the expression of procollagen, alpha-smooth muscle actin, and transforming growth factor-beta1 in comparison to rats without PGZ.	Pioglitazone	49-52	actin gamma 2, smooth muscle	Rattus norvegicus	132-195	
11829461-2	2002	Pioglitazone (1 mg/kg BW) prevented pericentral fibrosis and induction of alpha-smooth muscle actin (SMA) 72 h after CCl(4) administration (1 ml/kg BW).	Pioglitazone	0-12	actin gamma 2, smooth muscle	Rattus norvegicus	101-104